Anasarca Secondary to Protein-Losing Enteropathy Leading to the Diagnosis of a Gastrointestinal Neuroendocrine Tumor in a Young Female: A Case Report From an Indian Suburb.
anasarca
fecal alpha 1 antitrypsin
gastric neuroendocrine tumors
protein-losing enteropathy
tumor marker
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Jul 2024
Jul 2024
Historique:
accepted:
30
07
2024
medline:
31
8
2024
pubmed:
31
8
2024
entrez:
30
8
2024
Statut:
epublish
Résumé
A 34-year-old woman presented with worsening generalized swelling and breathlessness for four months; physical examination showed pallor, diffuse anasarca, and bilateral crackles on respiratory auscultation. Laboratory investigations showed severe hypoproteinemia, fat malabsorption with fat-soluble vitamin deficiency, and significant protein loss in the stool. Imaging studies revealed pulmonary edema, ascites, bowel wall edema, and a duodenal polyp. Further evaluating the duodenal polyp, a grade two duodenal neuroendocrine tumor (NET) was identified. She was managed with subcutaneous octreotide and duodenal polypectomy, resulting in significant clinical improvement. This case highlights the importance of diagnosing and managing protein-losing enteropathy secondary to gastric neuroendocrine tumors.
Identifiants
pubmed: 39211694
doi: 10.7759/cureus.65745
pmc: PMC11361621
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Pagination
e65745Informations de copyright
Copyright © 2024, Shende et al.
Déclaration de conflit d'intérêts
Human subjects: Consent was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Références
Pancreas. 2010 Aug;39(6):707-12
pubmed: 20664470
Am J Clin Oncol. 2008 Feb;31(1):64-70
pubmed: 18376230
N Engl J Med. 2023 Aug 24;389(8):733-748
pubmed: 37611123
J Vet Intern Med. 2019 Mar;33(2):383-402
pubmed: 30762910
CA Cancer J Clin. 2011 Mar-Apr;61(2):113-32
pubmed: 21388967
Cureus. 2021 Nov 12;13(11):e19501
pubmed: 34912640
CMAJ. 2017 Mar 13;189(10):E398-E404
pubmed: 28385820
World J Clin Cases. 2021 May 26;9(15):3758-3764
pubmed: 34046480
Endocr Pathol. 2022 Mar;33(1):115-154
pubmed: 35294740
J Clin Med. 2023 Aug 05;12(15):
pubmed: 37568540
Clin Exp Gastroenterol. 2017 Jul 17;10:147-168
pubmed: 28761367
Pancreas. 2020 Oct;49(9):1123-1130
pubmed: 32991344
Digestion. 2011;84(3):199-206
pubmed: 21757911